You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR PROLIXIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for PROLIXIN

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02203786 ↗	D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement	Completed	Canadian Institutes of Health Research (CIHR)	Phase 2	2009-09-01	To determine if: 1. pathological gambling is similar to psychostimulant addiction as reflected by parallel roles for D1 and D2 receptors in gambling and stimulant reinforcement. 2. these parallel roles are linked with gambling pathology or if they are evident in both gamblers and controls.
NCT02203786 ↗	D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement	Completed	Centre for Addiction and Mental Health	Phase 2	2009-09-01	To determine if: 1. pathological gambling is similar to psychostimulant addiction as reflected by parallel roles for D1 and D2 receptors in gambling and stimulant reinforcement. 2. these parallel roles are linked with gambling pathology or if they are evident in both gamblers and controls.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for PROLIXIN

Condition Name

Chart
Table

Condition Name for PROLIXIN
Intervention	Trials
Pathological Gambling	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for PROLIXIN
Intervention	Trials
Gambling	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PROLIXIN

Trials by Country

Map
Table

Trials by Country for PROLIXIN
Location	Trials
Canada	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PROLIXIN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for PROLIXIN
Clinical Trial Phase	Trials
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for PROLIXIN
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PROLIXIN

Sponsor Name

Chart
Table

Sponsor Name for PROLIXIN
Sponsor	Trials
Canadian Institutes of Health Research (CIHR)	1
Centre for Addiction and Mental Health	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for PROLIXIN
Sponsor	Trials
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.